Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Statistics

Total Valuation

SLNO has a market cap or net worth of $3.38 billion. The enterprise value is $3.11 billion.

Market Cap	3.38B
Enterprise Value	3.11B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

SLNO has 45.86 million shares outstanding. The number of shares has increased by 143.61% in one year.

Current Share Class	45.86M
Shares Outstanding	45.86M
Shares Change (YoY)	+143.61%
Shares Change (QoQ)	+4.89%
Owned by Insiders (%)	1.86%
Owned by Institutions (%)	78.99%
Float	31.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.74
P/TBV Ratio	14.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.68, with a Debt / Equity ratio of 0.22.

Current Ratio	15.68
Quick Ratio	15.55
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-798.39

Financial Efficiency

Return on equity (ROE) is -87.35% and return on invested capital (ROIC) is -50.57%.

Return on Equity (ROE)	-87.35%
Return on Assets (ROA)	-45.06%
Return on Invested Capital (ROIC)	-50.57%
Return on Capital Employed (ROCE)	-59.07%
Revenue Per Employee	n/a
Profits Per Employee	-$1.91M
Employee Count	92
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +77.56% in the last 52 weeks. The beta is -2.29, so SLNO's price volatility has been lower than the market average.

Beta (5Y)	-2.29
52-Week Price Change	+77.56%
50-Day Moving Average	50.31
200-Day Moving Average	49.27
Relative Strength Index (RSI)	78.59
Average Volume (20 Days)	2,076,291

Short Selling Information

The latest short interest is 4.99 million, so 10.88% of the outstanding shares have been sold short.

Short Interest	4.99M
Short Previous Month	4.81M
Short % of Shares Out	10.88%
Short % of Float	15.93%
Short Ratio (days to cover)	8.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-184.43M
Pretax Income	-65.41M
Net Income	-175.85M
EBITDA	-182.44M
EBIT	-184.43M
Earnings Per Share (EPS)	-$4.38

Balance Sheet

The company has $291.44 million in cash and $52.83 million in debt, giving a net cash position of $265.82 million or $5.80 per share.

Cash & Cash Equivalents	291.44M
Total Debt	52.83M
Net Cash	265.82M
Net Cash Per Share	$5.80
Equity (Book Value)	245.11M
Book Value Per Share	5.36
Working Capital	275.14M

Cash Flow

In the last 12 months, operating cash flow was -$69.10 million and capital expenditures -$218,000, giving a free cash flow of -$69.31 million.

Operating Cash Flow	-69.10M
Capital Expenditures	-218,000
Free Cash Flow	-69.31M
FCF Per Share	-$1.51

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLNO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-143.61%
Shareholder Yield	-143.61%
Earnings Yield	-5.21%
FCF Yield	-2.05%

Analyst Forecast

The average price target for SLNO is $95.75, which is 29.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$95.75
Price Target Difference	29.97%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 26, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 26, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2